Technology Holdings
Closed
Advertisement
115 Pitt St
Sydney, New South Wales 2000
BioFarmag Limited, established in 2004, is pioneering a revolutionary non-invasive test for breast cancer detection by utilizing synchrotron X-ray diffraction of hair samples. This innovative approach aims to provide early detection for women from as young as 20 years old, potentially enhancing treatment options and survival rates.
The company's technology leverages the unique properties of hair, which can reflect an individual's biomedical and environmental history over time. Currently in trial phases, the BioFarmag Test has shown promising results during its 2000-patient validation trial, achieving an accuracy rate of 69.75% after excluding damaged hair.
Generated from the website
Also at this address
See a problem?
You might also like
Advertisement
